Scientific evidence of commercial artificial intelligence products for pulmonary nodule assessment on CT scans: a systematic review - Takeaways - MDSpire

Scientific evidence of commercial artificial intelligence products for pulmonary nodule assessment on CT scans: a systematic review

  • By

  • Jasika Paramasamy

  • Asabi Leliveld

  • Jan-Willem Groen

  • Bo Willems

  • Joachim G. J. V. Aerts

  • Aad van der Lugt

  • Ties A. Mulders

  • Arlette E. Odink

  • Jacob J. Visser

  • July 15, 2026

Share

  • 1

    Lung cancer is the leading cause of cancer-related mortality, making early diagnosis crucial for improving patient outcomes.

  • 2

    AI technologies, including CADe and CADx, are being researched to assist radiologists in detecting and analyzing pulmonary nodules on CT scans.

  • 3

    A systematic review was conducted to evaluate the efficacy of CE-certified and FDA-cleared AI software for lung nodule assessment.

  • 4

    The review adhered to PRISMA guidelines and included studies published from January 2012 to November 2024.

  • 5

    Studies were selected based on specific criteria, focusing on the validation of AI software for lung nodule assessment on CT scans.

Original Source(s)

Scientific evidence of commercial artificial intelligence products for pulmonary nodule assessment on CT scans: a systematic review

  • by Jasika Paramasamy, Asabi Leliveld, Jan-Willem Groen, Bo Willems, Joachim G. J. V. Aerts, Aad van der Lugt, Ties A. Mulders, Arlette E. Odink, Jacob J. Visser

  • July 15, 2026

Related Content

Evidence-Based Imaging Pathway for Atrial Fibrillation Ablation

Predictive models for intestinal obstruction: from clinical scores to artificial intelligence

A review of the application of novel intervertebral disc diagnostic technologies integrated with artificial intelligence in medical imaging